about
A novel calpain inhibitor, ((1S)-1((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl) carbamic acid 5-methoxy-3-oxapentyl ester, protects neuronal cells from cerebral ischemia-induced damage in miceImmunoreactivity of growth inhibitory factor in normal rat brain and after stab wounds--an immunocytochemical study using confocal laser scan microscopeMetallothionein-III knockout mice aggravates the neuronal damage after transient focal cerebral ischemiaBiochemistry and neurobiology of prosaposin: a potential therapeutic neuro-effector.Roles and therapeutic potential of metallothioneins in neurodegenerative diseases.Protective function of SLC30A10 induced via PERK-ATF4 pathway against 1-methyl-4-phenylpyridinium.Protective roles of SLC30A3 against endoplasmic reticulum stress via ERK1/2 activation.Characterization of canine dental pulp cells and their neuroregenerative potential.Conditioned medium of dental pulp cells stimulated by Chinese propolis show neuroprotection and neurite extension in vitro.Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models.Living with idiopathic basal ganglia calcification 3: a qualitative study describing the lives and illness of people diagnosed with a rare neurological disease.Review of relevance between metal homeostasis and neurodegenerative disease.Neuroprotective effect of 5-aminolevulinic acid against low inorganic phosphate in neuroblastoma SH-SY5Y cells.Brain injury and growth inhibitory factor (GIF)--a minireview.The effects of Brazilian green propolis that contains flavonols against mutant copper-zinc superoxide dismutase-mediated toxicity.Localization of type-III sodium-dependent phosphate transporter 2 in the mouse brain.The type III transporters (PiT-1 and PiT-2) are the major sodium-dependent phosphate transporters in the mice and human brains.Induced pluripotent stem cells derived from a patient with familial idiopathic basal ganglia calcification (IBGC) caused by a mutation in SLC20A2 gene.Neuromyelitis optica in Japanese sisters.Microarray analysis of the liver in metallothionein-III null mice treated with cadmium.Motor-dominant chronic inflammatory demyelinating polyneuropathy.Serial monitoring of basal metabolic rate for therapeutic evaluation in an Isaacs' syndrome patient with chronic fluctuating symptoms.High prevalence of autoantibodies against phosphoglycerate mutase 1 in patients with autoimmune central nervous system diseases.Attenuation of cadmium-induced testicular injury in metallothionein-III null mice.Selective cauda equina hypertrophy with idiopathic inflammation.ITIH4 and Gpx3 are potential biomarkers for amyotrophic lateral sclerosis.A novel monoclonal antibody which reacts with a high molecular weight neuronal cytoplasmic protein and myelin basic protein (MBP) in a patient with macroglobulinemia.Venous congestive myelopathy of the cervical spinal cord: an autopsy case showing a rapidly progressive clinical course.Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia.Autoantibodies against glutamate receptor epsilon2-subunit detected in a subgroup of patients with reversible autoimmune limbic encephalitis.Administration of prosaposin ameliorates spatial learning disturbance and reduces cavity formation following stab wounds in rat brain.Anti-endothelial cell antibodies in patients with cerebral small vessel disease.Cilostazol reduces ischemic brain damage partly by inducing metallothionein-1 and -2.Metallothionein-3 deficient mice exhibit abnormalities of psychological behaviors.Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch.Occurrence of myelin-associated glycoprotein (MAG)-like immunoreactivity in some nervous, endocrine, and immune-related cells of the rat. An immunohistochemical study.Sporadic amyotrophic lateral sclerosis of long duration is associated with relatively mild TDP-43 pathology.Patterns of growth inhibitory factor (GIF) and glial fibrillary acidic protein relative level changes differ following left middle cerebral artery occlusion in rats.Is there delayed gastric emptying in patients with multiple system atrophy? An analysis using the (13)C-acetate breath test.
P50
Q28296038-23DBF8B4-BC2C-4699-91B7-6A4CFFAE17ADQ28577419-75FF72B1-F962-4CD7-B8E1-3F1585F771A9Q28593049-F872F711-C8F0-43FB-A05B-B4499A6368E5Q37658945-994C6DEE-335A-4583-8DF4-6ACF1B3B4FDBQ38099352-52F04A67-D0CB-4ABA-BB6D-DE0AD76CC4F7Q38697815-FBFBC134-C200-4689-8A81-3947F7EDC395Q38743441-B56E6AE3-3522-4897-8CD5-2B01E9AFCBE2Q38853449-573F93C8-AE5F-48FA-B3CA-C14BE5100638Q38918973-3C8CD3BD-945D-42D3-A1FA-2485153288FCQ39021126-10D6A3C2-FEF1-4FE4-B068-581EEC1A5461Q39043882-20DB608E-FA0C-42AC-A8B1-746FF76ACF05Q39252480-5C9C7341-5CFC-472C-978E-64E9C8C0187FQ39424286-4D938AD7-150B-43E5-8E87-AC50963DCBD8Q41050949-6B891CF0-D439-4A46-95C0-61297461B1A5Q41712450-7305B298-845D-4AB9-8AC8-3DE409EE9EF8Q42220038-0E6C3780-99A7-4DC1-A3E3-0164E1A0DF0BQ42442533-04AB3051-12BA-4E6B-A65B-4129064055E1Q42489648-02097313-9494-48CE-82DF-0D7D397FD7E1Q42516885-3D807413-15A0-445A-B9BF-BB7E7C174C4CQ42624968-B542DC22-E7C1-4A63-88FD-D899A847F80AQ43107927-59C172FE-AEA2-4BD9-BE42-CAB64EA2BB21Q43111229-A52AD26E-2422-4D0B-85E6-BE90AAA6F4C5Q43146923-7BA12ACC-EBAC-4511-B201-C7268BEF7240Q43227730-8E7B46EF-68D4-4B68-A687-F059FB3F45CEQ45585035-312D88DD-2E6F-41D4-89BC-4FDE5904472FQ46553570-67577AB9-9146-4B9B-9628-9A8A24870036Q46935418-12E38F59-B6E7-4D13-9721-7C4C08E520E9Q47310197-3040AC97-9F8C-4E41-B260-65883AC82A2FQ48098451-77C18BD0-07F7-467F-A99A-B2907CFDEFF6Q48108493-DAC8EEB4-31CA-4ACE-B4AB-F7AF193C1CBBQ48109738-994E4015-EFAA-47DF-BEF9-8C80471CAB8BQ48167359-971590EC-406A-41DC-9F72-1020155B39A4Q48352923-EF1BA909-8A31-4249-BCCF-AD441EA20DE8Q48429357-AEF63158-1711-4BD9-AFB1-0274E7EB9016Q48444031-B5F69EFB-D90F-4C1A-B8DF-34D8E97DC430Q48537185-D0AFA962-363A-4212-A77E-ECE742709EC2Q48710261-8708B793-4D9E-424C-9C9B-18AD85FB42D4Q48879152-FB7075FA-1F33-4816-AB14-C4303516CB70Q49117452-2068B7F8-4AA7-4FF2-B9C4-2C18E7032259Q51457502-2F3392EE-5C44-4D02-A3A2-7547944DEFBE
P50
description
researcher ORCID 0000-0003-0984-6291
@en
wetenschapper
@nl
name
Isao Hozumi
@ast
Isao Hozumi
@en
Isao Hozumi
@es
Isao Hozumi
@nl
type
label
Isao Hozumi
@ast
Isao Hozumi
@en
Isao Hozumi
@es
Isao Hozumi
@nl
prefLabel
Isao Hozumi
@ast
Isao Hozumi
@en
Isao Hozumi
@es
Isao Hozumi
@nl
P106
P1153
6603751817
P31
P496
0000-0003-0984-6291